Karuna Therapeutics is a clinical-stage biopharmaceutical company that is driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Karuna understands that there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by serious mental illness. By utilizing its extensive knowledge of neuroscience, Karuna is harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives.